Erythropoietin effectiveness index. A quantitative definition of resistance in haemodialysis patients with adequate iron stores

Clinical Drug Investigation

Volumn 15, Issue 1, 1998, Pages 57-60

  Bailie, George R ^a,c   Low, Chai Luan ^b   Eisele, George ^c  

^a ALBANY COLLEGE OF PHARMACY AND HEALTH SCIENCES   (United States)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^c ALBANY MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ERYTHROPOIETIN; IRON;

ADULT; AGED; ARTICLE; DRUG EFFICACY; DRUG RESISTANCE; FEMALE; HEMODIALYSIS PATIENT; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; IRON STORAGE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

EID: 0031951046     PISSN: 11732563     EISSN: None     Source Type: Journal    
DOI: 10.2165/00044011-199815010-00007     Document Type: Article

References (12)

1. Kleiner MJ, Van Wyck DB, Kaupke CJ, et al. The role of iron and other factors in patients unresponsive to erythropoietin therapy. Semin Dial 1995; 8: 29-34
2. Barany P, Divino Filho JC, Bergstrom J. High C-reactive protein is a strong predictor of resistance to erythropoietin in hemodialysis patients. Am J Kidney Dis 1997; 29: 565-8
3. Sunder-Plassmann G, Horl WH. Erythropoietin and iron. Clin Nephrol 1997; 47: 141-57
4. Fishbane S, Maesaka JK. Iron management in end-stage renal disease. Am J Kidney Dis 1997; 29: 319-33
5. Fishbane S, Frei GL, Maesaka J. Reduction in recombinant human erythropoietin doses by the use of chronic intravenous iron supplementation. Am J Kidney Dis 1995; 26: 41-6
6. Sepandj F, Jindal K, West M, et al. Economic appraisal of maintenance parenteral iron in treatment of anaemia in chronic hemodialysis patients. Nephrol Dial Transplant 1996; 11: 319-22
7. Macdougall IC. Poor response to erythropoietin: practical guidelines on investigation and management. Nephrol Dial Transplant 1995; 10: 607-14
8. Besarab A. Optimizing erythropoietin therapy in end-stage renal disease: the case for subcutaneous administration. Am J Kidney Dis 1993; 22 Suppl. 1: S13-S22
9. Muirhead N, Bargman J, Burgess E, et al. Evidence-based recommendations for the clinical use of recombinant human erythropoietin. Am J Kidney Dis 1995; 26 Suppl. 1: S1-S24
10. Hatton RC, Portales I, Finlay A, et al. Removal of iron dextran by hemodialysis: an in vitro study. Am J Kidney Dis 1995; 26: 327-30
11. Bailie GR, Handa J, Tang L, et al. Minimal removal of iron-dextran by conventional haemodialysis: an in vivo study. Clin Drug Invest 1997; 14: 12-5
12. National Kidney Foundation Dialysis Outcomes Quality Inititative. Clinical practice guidelines for the treatment of anemia of chronic renal failure. Am J Kidney Dis 1997; 30 Suppl.